A Phase II Trial of Trastuzumab-pkrb Combined With Modified FOLFOX-6 in Biliary Tract Cancer Patients Progressed on First Line Therapy
Latest Information Update: 13 Oct 2023
Price :
$35 *
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; Oxaliplatin (Primary) ; Trastuzumab (Primary)
- Indications Biliary cancer; Cholangiocarcinoma; Gallbladder cancer; Periampullary cancer
- Focus Therapeutic Use
- 10 Oct 2023 Status changed from recruiting to completed.
- 07 Jun 2022 Primary endpoint (Objective response rate (ORR)) has been met as per results presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology